FDA Inspection 921138 — R. Doyle Stulting, MD

R. Doyle Stulting, MD — FEI 3010543346

The FDA completed an inspection of R. Doyle Stulting, MD on January 22, 2015 in Atlanta, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 22, 2015
Fiscal Year
2015
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Atlanta, GA (United States)

Additional Details

Clinical Investigator (CI)